Both treatment groups demonstrated a significant reduction in number of bleeding sites relative to baseline ( p < 0.0001 ) ; however , a significant difference in percent reduction in favor of Elite relative to MTB was found at week four : 82.5 % vs. 75.8 % ( p = 0.026 ) .
